AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Highlights
- Significant increase in institutional holdings of Maximus, Inc. during the fourth quarter, highlighting growing investor confidence.
- The company's stock has experienced notable price fluctuations, with a 52-week range between $64.53 and $93.97.
- Maximus announced a quarterly dividend with a yield of 1.82%, reflecting steady income generation for shareholders.
Maximus, Inc. (NYSE:MMS) has witnessed a considerable increase in institutional holdings. Allworth Financial LP notably increased its position by 1,638.4%, owning 1,495 shares by the end of the fourth quarter, valued at approximately $116,000. Other significant investors include UMB Bank n.a., Eastern Bank, and V Square Quantitative Management LLC, all of which have augmented their stakes, highlighting growing market interest.
Maximus's stock performance shows a dynamic 52-week range, with a low of $64.53 and a high of $93.97. As of Monday, the stock opened at $65.95. Analysts forecast an earnings per share of $6.15 for the fiscal year, reflecting robust profitability and strategic management advancements.
Financial Stability and Dividend Announcements
The company maintains strong financial ratios, with a current and quick ratio both standing at 1.72, supported by a debt-to-equity ratio of 0.82. This financial solidity is complemented by a market capitalization of $3.73 billion and a P/E ratio of 14.18. Meanwhile, Maximus is distributing a quarterly dividend of $0.30 per share, amounting to an annualized dividend of $1.20 and a yield of 1.82%, ensuring a consistent income stream for investors.
Insider Transactions and Strategy
Corporate insiders, including Director Raymond B. Ruddy and insider Michelle F. Link, engaged in significant buying and selling activities in the last quarter. Ruddy's purchase increases his holdings by 3.20%, while Link's sale represents a 25.16% decrease in ownership. Such transactions could provide insight into insider perspectives on stock valuation and corporate growth prospects.
Analyst Coverage and Corporate Overview
Analyst sentiment shows varied opinions. While Raymond James upgraded Maximus to an “outperform” rating and set a $90.00 target price, StockNews.com adjusted its view from a “buy” to a “hold.” Maximus operates through three segments, focusing on U.S. Federal Services, U.S. Services, and international operations, delivering government services including program eligibility support and independent health assessments.
Maximus, Inc. represents a notable entity within the health services sector, characterized by substantial institutional interest, prudent financial management, and solid dividend offerings. The current positioning could appeal to investors focusing on medium to long-term growth and stable income.
